CancerIQ Launches Research Initiative to Quantify Downstream Value of Digitally Enabled Cancer Risk Programs
CHICAGO, April 19, 2024 /PRNewswire-PRWeb/ -- CancerIQ, a best-in-class cancer-focused precision health platform, today announced it is seeking health systems to participate in the newly launched, large-scale research effort that will document the downstream revenue of digital interventions for genetically informed cancer prevention, early detection and treatment. The "Validating Applications for Long-term Utility and Enhanced ROI" (VALUE) in Cancer Risk Programs Study aims to bring together health systems from across the country to advance understanding of the system-level financial value of genetics and genomics.